MSCT perfusion imaging and its correlation with perfusion parameters, survivin expression, MVD, and pathologic grade in hepatocellular carcinomas

Journal of Central South University (Medical Sciences)

Volumn 34, Issue 11, 2009, Pages 1096-1102

  Long, Xueying ^a   Cao, Jue ^a   Shi, Linbo ^a   Li, Wenzheng ^a   Hui, Liu ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Microvessal density; Perfusion imaging; Survivin; Tomography; X ray computed

Indexed keywords

BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; FEMALE; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; METHODOLOGY; MICROVASCULATURE; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; SCINTIGRAPHY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; VASCULARIZATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LIVER NEOPLASMS; MALE; MICROVESSELS; MIDDLE AGED; PERFUSION IMAGING; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 73349093739     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Kawasaki H, Toyoda M, Shinohara H, et al. Expression of survivin correlate with apoptosis, proliferation, and angiogene-sis during human colorectal tumorigenesis [J]. Cancer, 2001, 91(11): 2026-2032.
2. Harfouche R, Hassessian H M, Guo Y, et al. Mechanisms which mediate the antiapoptotic effects of angiopoietin -1 on endothelial cells [J]. Microvasc Res, 2002, 64 (1): 135-147.
3. Mesri M, Morales-Ruiz M, Ackermann E J, et al. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by surviving targeting [J]. Am J Pathol, 2001,158(5):1757-1765.
4. Kanematsu M, Osada S, Amaoka N, et al. Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver: correlation with angiographically assisted CT[J]. Am J Roentgenol, 2004, 183 (6):1585-1593.
5. LIU Hui, CAO Jue, PENG Guangchun, et al. Correlation between CT perfusion parameter of hepatocellular carcinoma and expression of VEGF [J]. Chinese Journal of Medical Imaging, 2005, 13(4):244-247.
6. Van Beers B E, Leconte I, Materne R, et al. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity [J]. Am J Roentgenol, 2001, 176(3):667-673.
7. Miles K A, Leggett D A, Kelley B B, et al. In vivo assessment of neovascularization of liver metastases using perfusion CT[J]. Br J Radiol, 1998, 71 (843):276-281.
8. Tsushima Y, BlomLey M, Kusano S, et al. Measuring portal venous perfusion with contrast - enhance CT: Comparison of direct and indirect methods[J]. Academ Radiol, 2002, 9 (3):276-282.
9. CAO Jue, YANG Ang, LONG Xueying, et al. CT hepatic volume measurement combining rwith CT perfusion imaging in eevaluating the hepatic functional reserve [J]. Journal of Central South University. Medical Science,2007,32(3): 422-426.
10. Shankar S L, Mani S, O'Guin K N, et al. Survivin inhibition induces human neural tumor cell death through caspase-independent pathways [J]. J Neurochem,2001,79(2): 426-436.
11. O'Connor D S, Schechner J S, Adida C, et al. Control of apoptosis during angiogenesis by surviving expression in endothelial cells [J]. Am J Pathol, 2000, 156 (2):393-398.
12. Messerini L, Novelli L, Comin C E. Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma [J]. J Clin Pathol, 2004, 57(8):867-871.
13. Asayama Y, Yoshimitsu K, Nishihara Y, et al. Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation [J]. Am J Roentgenol,2008, 190(1):W28-34.
14. Ippolito D, Sironi S, Pozzi M, et al. Perfusion computed tomographic assessment of early hepatocellular carcinoma in cirrhotic liver disease: initial observations [J]. J Comput Assist Tomogr, 2008,32 (6):855-858.